Evidence map›Paper›PMID 42026762›Full record

ArticleGut microbes2026

Microbial metabolite Enterobactin impairs mitochondrial respiration and alleviates colitis.

Vinita Kushwaha, Beng San Yeoh, Piu Saha, Benoit Chassaing, Bina Joe, Andrew T Gewirtz, Matam Vijay-Kumar

Abstract read
In one paragraph

Article in Gut microbes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vinita KushwahaUT Microbiome Consortium, Department of Physiology & Pharmacology, The University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
Beng San YeohUT Microbiome Consortium, Department of Physiology & Pharmacology, The University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
Piu SahaUT Microbiome Consortium, Department of Physiology & Pharmacology, The University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
Benoit ChassaingMicrobiome-Host Interactions, Institut Pasteur, Université Paris Cité, INSERM U1306, Paris, France.ORCID 0000-0002-4285-769X
Bina JoeUT Microbiome Consortium, Department of Physiology & Pharmacology, The University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
Andrew T GewirtzCenter for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia.
Matam Vijay-KumarUT Microbiome Consortium, Department of Physiology & Pharmacology, The University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.ORCID 0000-0002-8732-0167

Funding

Role of neutrophil extracellular traps (NETs) in Inflammatory bowel diseaseR01DK134053 · NIDDK · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI MATAM VIJAY-KUMAR · 2023 to 2026
$1.7M
NIDDK NIH HHS R01 DK134053
6 · The paper itself

Abstract

BACKGROUND AND

aimsHost-microbe interactions critically shape cellular metabolism and immune responses. The bacterial siderophore enterobactin (Ent) is known for pilfering iron from the host, but recent evidence suggests that it may also deliver iron to host mitochondria. Its impact on mitochondrial respiration, however, remains poorly understood. Here, we assess the interplay among Ent, iron, and lipocalin-2 (Lcn2, which sequesters Ent) on mitochondrial function. We also examine the effects of the 2, 3-dihydroxybenzoic acid (2, 3-DHBA), the monomeric derivative of Ent, and the mammalian siderophore 2, 5-DHBA in a murine model of colitis.

methodsMurine bone marrow-derived macrophages (BMDMs) and the human model intestinal epithelial cells (IEC) were treated with Ent, with or without iron or rec-Lcn2, and mitochondrial respiration was assessed via Seahorse XFe96 analyzer. For

resultsIron-free Ent impaired mitochondrial oxidative phosphorylation in BMDMs and IEC, as evidenced by reduced ATP production and elevated reactive oxygen species. These effects of Ent were mitigated by iron saturation or upon co-administered with rec-Lcn2. Intriguingly, administration of 2, 3-DHBA, but not 2, 5-DHBA, to mice with DSS-induced colitis attenuated inflammation, increased expression of tight junction proteins, preserved epithelial architecture, and promoted mucosal repair. 2, 3-DHBA treatment also enhanced mitochondrial biogenesis, dynamics, and redox balance.

conclusionsEnt in its 2, 3-DHBA form confers mucosal protection, despite its inhibitory effects on mitochondrial respiration. These findings suggest that modulating mitochondrial activity, thus reducing cellular metabolism, may be beneficial during colitis and position 2, 3-DHBA as a promising microbiota-derived metabolite for therapeutic intervention in inflammatory bowel disease.

Indexed as

ColitisEnterobactinMitochondriaAnimalsDextran SulfateDisease Models, AnimalEpithelial CellsGentisatesHumansHydroxybenzoatesIntestinal MucosaIronLipocalin-2MacrophagesMaleMice2,3-dihydroxybenzoic acidDextran SulfateEnterobactinGentisatesHydroxybenzoatesIronLcn2 protein, mouseLipocalin-2Iron chelationLipocalin-2mammalian siderophoreoxidative phosphorylation

Identifiers

PMID42026762
PMCPMC13114135

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.